DSG3 has been identified as an autoantigen in the skin disease pemphigus vulgaris [41] and is also upregulated in several cancers, including squamous cell carcinoma, pancreatic ductal adenocarcinoma, and head and neck cancer [40, 42, 43]. Here, DSG3 is linked to pancreatic ductal adenocarcinoma.